bioAffinity Technologies, Inc. Profile Avatar - Palmy Investing

bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targe…

Medical - Diagnostics & Research
US, San Antonio [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

bioAffinity Technologies, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

bioAffinity Technologies, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of bioAffinity Technologies, Inc..

End of BIAF's Analysis
CIK: 1712762 CUSIP: 09076W109 ISIN: US09076W1099 LEI: - UEI: -
Secondary Listings
BIAF has no secondary listings inside our databases.